Global Liquid Biopsy Markets Market Report 2016-2020 - Blood Tests Replace Surgical Biopsies / Single Screening Test for all Cancers Announced

Jan 28, 2016, 02:10 ET from Research and Markets

DUBLIN, January 28, 2016 /PRNewswire/ --

Research and Markets ( has announced the addition of the "Liquid Biopsy Markets Global Market Size, Strategies and Forecasts 2016 to 2020" report to their offering. 

     (Logo: )

The Diagnostic, Monitoring and Screening Test opportunities are explored. 

A revolution in cancer diagnostics is occurring using in vitro blood testing to identify cancer DNA. GRAIL, a new company with impressive backing, has announced a single blood test to detect all cancers. The technology is moving faster than the market. New technology that definitively identifies disease conditions from blood samples is poised to replace expensive invasive surgical biopsy procedures. The market is still in its infancy but has outstanding growth potential. The impact on the health care industry is enormous. The report forecasts the market size out to 2020. In addition, the report looks at potential market sizes by country, by cancer and by the three different opportunities: detection, management and screening. 

Use independent research that makes you the expert. Get our research team working for you by ordering all, or a portion, of this comprehensive report. Your credit card order sends the report to your inbox instantly. Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade to more information. We wrote this report and we are ready, by phone or email, to help you use it. 

Circulating Tumor Cells? Cell Free DNA? Exosomes? Find out about the technology in readily understood terms that explain the jargon. Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size. 

The report includes detailed breakouts for 15 Countries and 4 Regions along with breakouts for Lung, Breast, Colorectal, Prostate and Other Cancers. What is the size of the huge screening opportunity? 

Key Topics Covered: 

1. Introduction and Market Definition 

2. Market Overview 

3. Market Trends 

4. Liquid Biopsy Recent Developments 

5. Country Market Sizes - North America 

6. Country Markets - Europe 

7. Country Markets - Asia Pacific 

8. Country Markets - Latin America, Africa & The Middle East 

9. Global Market Summary 

10. Potential Market Opportunity Sizes 

Companies Mentioned 

- AdnaGen (now Qiagen)
- Agena Bioscience
- Angle plc
- ApoCell
- AstraZeneca
- Baylor
- Bio-Rad Laboratories
- BioFluidica
- Biocept
- Biodesix
- Boreal Genomics
- Broad Institute
- CRUK Manchester Institute
- Chronix Biomedical
- Clearbridge BioMedics
- Cynvenio
- CytoTrack
- Cytolumina Technologies Corp
- Diagnologix LLC
- Epic Sciences
- Exosome
- Fluidigm Corp
- Fluxion Biosciences
- Genomic Health
- Guardant Health
- HTG Molecular Diagnostics
- HansaBiomed
- Horizon Discovery
- Illumina
- Inivata
- Janssen Diagnostics
- Merck Serono
- Molecular MD

For more information visit

About Research and Markets 

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:  

Laura Wood

SOURCE Research and Markets